In addition, the combined ascitic ADA and tumor marker (positive ascitic tumor makers and ADA < 22.50 IU/L) had 100% of the specificity in diagnosing PC, which could excellently rule out benign ascites in clinical practice. The gene discussed is ADA; the disease is neoplasm.